ESMO Clinical Practice Guidelines: Haematological Malignancies

The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.

Latest enhanced and revised set of guidelines

ESMO has Clinical Practice Guidelines on the following Haematological Malignancies: Philadelphia chromosome-negative chronic myeloproliferative neoplasms, Hairy cell leukaemia, Peripheral T-cell lymphomas, Myelodysplastic syndromes, Waldenström's macroglobulinaemia, Multiple myeloma, Acute myeloblastic leukaemia in adult patients, Chronic lymphocytic leukaemia, Chronic myeloid leukemia, Hodgkin's lymphoma, Mantle cell lymphoma, Diffuse large B-cell lymphoma, Gastric marginal zone lymphoma of MALT type, Primary cutaneous lymphoma and Newly diagnosed and relapsed follicular lymphoma.

They include information on incidence, diagnosis, staging and risk assessment, treatment, response evaluation and follow-up.